Steen R G, Taylor J S, Langston J W, Glass J O, Brewer V R, Reddick W E, Mages R, Pivnick E K
Department of Diagnostic Imaging, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.
AJNR Am J Neuroradiol. 2001 May;22(5):810-7.
Mutation of the neurofibromatosis type 1 (NF-1) gene may be associated with abnormal growth control in the brain. Because macrocephaly could be a sign of abnormal brain development and because 30% to 50% of children with NF-1 display macrocephaly in the absence of hydrocephalus, we sought to determine the relationship between macrocephaly and other brain abnormalities in young subjects with NF-1. These subjects were free of brain tumor, epilepsy, or other obvious neurologic problems.
We prospectively screened 18 neurologically asymptomatic subjects with NF-1, ages 6 to 16 years, using clinical measures, psychometric testing, conventional MR imaging, and quantitative MR imaging to measure T1.
Cranial circumference was 2 or more SDs above the age norm in seven (39%) of 18 subjects, a frequency of macrocephaly 17-fold higher than normal. Conventional MR imaging showed abnormalities in all 18 children, although there were more extensive abnormalities in subjects with macrocephaly. Macrocephaly in NF-1 was associated with enlargement of multiple brain structures, and brain T1 in macrocephalic subjects was reduced with respect to controls in the genu, frontal white matter, caudate, putamen, thalamus, and cortex. In normocephalic subjects, T1 was reduced only in the genu and splenium. Volumetric analysis showed that macrocephaly was associated specifically with enlargement of white matter volume.
Neurologically asymptomatic children with NF-1 showed macrocephaly, cognitive deficit, enlarged brain structures, and abnormally low brain T1. Macrocephaly in children with NF-1 may be associated with characteristic alterations in brain development, marked by more widespread and significant changes in T1, greater enlargement of midline structures, and greater volume of white matter.
1型神经纤维瘤病(NF-1)基因的突变可能与大脑生长控制异常有关。由于巨头畸形可能是脑发育异常的一个迹象,且30%至50%的NF-1患儿在无脑积水的情况下表现出巨头畸形,我们试图确定NF-1年轻患者中巨头畸形与其他脑异常之间的关系。这些患者无脑肿瘤、癫痫或其他明显的神经问题。
我们前瞻性地筛查了18名年龄在6至16岁、无症状的NF-1神经学患者,采用临床测量、心理测试、传统磁共振成像以及定量磁共振成像来测量T1。
18名受试者中有7名(39%)的头围比年龄正常范围高出2个或更多标准差,巨头畸形的发生率比正常情况高17倍。传统磁共振成像显示所有18名儿童均有异常,不过巨头畸形患者的异常更为广泛。NF-1中的巨头畸形与多个脑结构增大有关,巨头畸形患者的脑T1在膝部、额叶白质、尾状核、壳核、丘脑和皮质处相对于对照组降低。在头围正常的受试者中,T1仅在膝部和压部降低。体积分析表明,巨头畸形与白质体积增大特别相关。
无症状的NF-1神经学儿童表现出巨头畸形、认知缺陷、脑结构增大以及脑T1异常降低。NF-1患儿的巨头畸形可能与脑发育的特征性改变有关,其特征为T1出现更广泛且显著的变化、中线结构增大更明显以及白质体积更大。